Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Recruiting
CT.gov ID
NCT05388201
Collaborator
Environmental Protection Agency (EPA) (U.S. Fed)
100
1
36
2.8

Study Details

Study Description

Brief Summary

This study examines the role of variations in the dimensions of facial features on the fitted filtering efficiency of face coverings available to the public during the COVID-19 pandemic. Approximately 100 young (18-55 years old) healthy participants will be recruited. Exclusionary criteria include pregnancy and breastfeeding. After informed consent, participants will enter a chamber where they will undergo 3D facial scanning using a dedicated camera system and be trained to don an N95 respirator properly. The fitted filtering efficiency (FFE) of 4 types of face coverings: a N95 respirator, a KN95 respirator (with and without a clip), a surgical mask (with and without a clip), and a KF94 respirator (with and without a clip) will be tested on each participant using the OSHA quantitative fit testing protocol for filtering face pieces.

Condition or Disease Intervention/Treatment Phase
  • Other: N95
  • Other: KN95
  • Other: KF94
  • Other: Surgical

Detailed Description

Consenting: The investigators will review the inclusion and exclusion criteria and any medical conditions that the participant may have or medications that they are currently taking. The investigators will go over the study protocol in detail so that the participant will know what to expect during the study procedure.

Lung Function Test: The participant will perform a breathing test (peak flow meter) before and after the facemask testing. This test measures the volume of air that the participant can blow out (exhale) quickly after taking a very deep breath. This is a method for measuring lung function and it must meet certain criteria prior to testing.

3D Facial Measurement and Imaging: The participants 3D facial features will be measured by facial calipers. Trained personnel (wearing gloves) will need to touch areas of the participants face and scalp to ensure proper caliper measurements are collected. A 3D picture of the participants face will be taken using a special 3D camera.

Video Instruction on Wearing an N-95 Respirator: The participant will watch a short video showing proper ways to wear an N-95 respirator.

Assessment of the Performance of Face Coverings: The participant will enter a study chamber where tiny sodium chloride (table salt) particles are emitted by a particle generator. The participant will be fit tested wearing different types of face coverings that include an N95-rated respirator, a KN95 mask (with and without clip), a surgical mask (with and without clip), and a KF94 respirator (with and without clip). During the test, the participant will be asked to perform a few tasks such as bending over, talking, etc. 3D images of the participants head, while wearing the masks, will be taken following each test.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
FACEFIT

Participants will enter a chamber where they will undergo 3D facial scanning using a dedicated camera system and be trained to don a N95 respirator properly. The fitted filtering efficiency (FFE) of 4 types of face coverings: a N95 respirator, a KN95 respirator (with and without a clip), a surgical mask (with and without a clip), and a KF94 respirator (with and without a clip) will be tested using the OSHA quantitative fit testing protocol for filtering face pieces. Participants will measure their peak expiratory flow pre and post mask fit testing using a disposable peak flow meter.

Other: N95
3M N95 Respirator

Other: KN95
KN95 Mask (with and without clip)

Other: KF94
KF94 Mask (with and without clip)

Other: Surgical
Surgical Mask (with and without clip)

Outcome Measures

Primary Outcome Measures

  1. Fitted Filtration Efficiency (FFE) [Approximately 5 minutes after each mask condition]

    A mask fit procedure will be performed based on a NIOSH (National Institute of Occupational Safety and Health) - approved protocol during the baseline visit. The efficiency of masks will be determined by a percentage of particle number measured behind the facemask over the particle number in the ambient air. Mask fit efficiency values from different levels of mask fit instructions will be compared.

  2. Craniofacial Morphology [Approximately 5 minutes before mask donning]

    Calipers will be used to measure 3D facial features of each subject. Trained personnel (wearing gloves) will need to touch areas of the subject's face and scalp to ensure proper caliper measurements are collected.

Secondary Outcome Measures

  1. 3D Facial Imaging [Approximately 5 minutes before mask donning and during mask donning]

    Subjects will self-administer a 3D scan of their face by aligning their head inside of an oval shown on the camera screen, triggering the camera shutter. The image takes about 3 seconds to generate and subjects will be asked to remain still during this time. The acquired facial images will be analyzed using digital image analysis software.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18-55 years old healthy male and female (BMI values between 19 and 33, inclusive).

  • Participants must be ambulatory and tolerate enclosed spaces.

  • Participants must be up to date with their COVID-19 vaccination status based on the current recommendations established by the CDC.

Exclusion Criteria:
  • Individuals with following conditions:

  • A history of acute or chronic cardiovascular disease, chronic respiratory disease, cancer, rheumatologic disease, neuromuscular disease, or immunodeficiency state.

  • Blood pressure readings equal to and greater than 140 systolic and equal to and greater than 90 diastolic.

  • Diabetes.

  • Asthma or a history of asthma.

  • Individuals who have unspecified illnesses, which in the judgment of the medical staff might increase the risk associated with saline aerosol inhalation will be a basis for exclusion.

  • Medications not specifically mentioned here may be reviewed by the medical staff prior to an individual's inclusion in the study. Use of other medications will be evaluated on a case-by-case basis. There is the potential that an individual's current medication use will preclude them from participating in the study at the current time, but they may be reassessed and potentially rescheduled for participation later based on the judgement of the medical staff.

  • Individuals who are pregnant, attempting to become pregnant or breastfeeding.

  • Individuals who are currently smoking (including vaping, hookah and e-cigarette) or have smoking history within 1 year of study or have a greater than/equal to a 5-pack year smoking history.

  • Individuals living with a smoker who smokes inside the house.

  • Individuals who are regularly exposed to high levels of vapors, dust, gases, or fumes.

  • Individuals who do not read, speak, or understand English well enough to give informed consent.

  • Individuals who are unwilling to shave facial hair.

  • Individuals who have orthopedic or balance issues that prevent them from performing the steps in the mask fit testing protocol, such as bending over, turning head left and right or up and down.

  • Individuals who recently had abdominal and/or eye surgery, or with any types of hernia, as well as any other contraindications for raised intra-abdominal pressure in the last 6 months.

Temporary exclusion criteria:
  • Individuals who have experienced any symptoms associated with acute respiratory illness within 4 weeks of enrollment.

  • Individuals who have active allergies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 U.S. Environmental Protection Agency Human Studies Facility Chapel Hill North Carolina United States 27514

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill
  • Environmental Protection Agency (EPA)

Investigators

  • Principal Investigator: James Samet, PhD, Environmental Protection Agency (EPA)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT05388201
Other Study ID Numbers:
  • 20-2612
First Posted:
May 24, 2022
Last Update Posted:
Aug 10, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of North Carolina, Chapel Hill
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022